Ask a Scientist: Treating Disease Earlier

As part of our bold ambition of one day eliminating cancer as a cause of death, we work with cutting-edge science at AstraZeneca every day. We know it’s important to make that science accessible to inspire the next generation of scientists.

As part of our ‘Ask a Scientist’ series, we’ve asked Serban Ghiorghiu, Vice President, Clinical Development, Oncology R&D, to explain how earlier detection and treatment of serious diseases, like cancer, can impact patient outcomes.

Learn more about our work in tumour drivers and resistance:

-----------------
Global site:

LabTalk Blog:

Careers site:

Follow us:
Twitter:
LinkedIn:
Instagram:
Facebook:

AstraZeneca,AZN,Pascal Soriot,zeneca,MedImmune,pharma,AstraZeneca Oncology,Serban Ghiorghiu,Cancer treatment,Cancer research,Oncology,Cancer biology,Disease,ASCO,American Society of Clinical Oncology Annual Meeting,STEM,Ask a scientist,Scientist,SciencefromAtoZ,science from a to z,cancer,